Shares of Icon were plummeting on Thursday toward their worst day in decades, as the announcement of an accounting probe added to all the pressures the contract research organization sector has already been feeling.
As a result of the investigation, which the company
ICLR said it initiated in October, the company withdrew its financial guidance for 2025, saying it plans to release fourth-quarter results “on or prior to” April 30, which would be about two months later than usual.
Why this drug-research company’s stock is having its worst day since 1999
Published:
Shares of Icon were plummeting on Thursday toward their worst day in decades, as the announcement of an accounting probe added to all the pressures the contract research organization sector has already been feeling.
As a result of the investigation, which the company
ICLR said it initiated in October, the company withdrew its financial guidance for 2025, saying it plans to release fourth-quarter results “on or prior to” April 30, which would be about two months later than usual.
Share this:
Related